Publications - Year 7

• Chi, KN, Zoubeidi A, Gleave ME, Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer. Expert Opin Investig Drugs. 2008;19(12):1955-62. PMID:19012510
  
  
  
• FitzGerald LM, Karlins E, Karyadi DM, Kwon EM, Koopmeiners JS, Stanford JL, Ostrander EA. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis. Prostate Cancer Prostatic Dis. 2009;12(2):192-7. PMID:18762813. NIHMS:71384
  
  
  
• FitzGerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Can Res. 2009 May 1;15(9):3231-7. PMCID:PMC2707085
  
  
  
• FitzGerald LM, Patterson B, Thomson R, Polanowski A, Quinn S, Brohede J, Thornton T, Challis D, Mackey DA, Dwyer T, Foote S, Hannan GN, Stankovich J, McKay JD, Dickinson JL. Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur J Hum Genet. 2009 Mar;17(3):368-77. PMID:18830231
  
  
  
• FitzGerald LM, Thomson R, Polanowski A, Patterson B, McKay JD, Stankovich J, Dickinson JL. Sequence variants of α-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population. Prostate. 2008 Sep;68(13):1373-9. PMID:18537123
  
  
• Harris JN, Bowen DJ, Kuniyuki A, McIntosh L, FitzGerald LM, Ostrander EA, Stanford JL. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives. Genet Med 2009 May;11(5):344-55. PMCID:PMC2683189
  
  
  
• Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL. Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev.  2009 Jun;18(6):1929-33. PMID:19454612. NIHMS:106140
  
  
  
• Lucas JM, True L, Hawley S, Matsumura M, Morrissey C, Vessella RL, Nelson PS. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J Pathol. 2008 Jun;215(2):118-25. PMID:18338334
  
  
  
• Morrissey C and Vessella RL. The role of tumor microenvironment in prostate cancer bone metastasis. Journal of Cellular Biochemistry. J Cell Biochem. 2007 Jul 1;101(4):873-86. PMID:17387734
  
  
  
• O'Sullivan J, Sheridan J, Mulcahy H, Tenniswood M, Morrissey C. The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats. Eur J Cancer Prev. 2008 Nov;17(6):489-501. PMID:18941371
  
  
  
• Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, et al. Australian Cancer Study; Australian Ovarian Cancer Study Group. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer. 2009 Jan 27;100(2):412-20. PMID:19127255
  
  
  
• Qian DZ, Huang CY, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS, Beer TM. Prostate cancer-associated gene expression alterations determined from needle biopsies. Clin Cancer Res. 2009 May 1;15(9):3135-42. PMID:19366833.
  
  
  
• Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate. 2009 Mar;69(4):363-72. PMID:19058137 NIHMS:105496
  
  
  
• Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet. 2009 May 15;18(10):1839-48. PMCID:PMC2671990
  
  
  
• Wright JL, DW Lin, Cowan JE, Carroll PR, Litwin MS and the CaPSURE Investigators.  Quality of life in young men after radical prostatectomy.  Prostate Cancer Prostatic Dis 2008;11(1):67-73.  PMID:17519925
  
  
  
• Wright JL, Lin DW, Porter MP. The association between extent of lymphadenctomy and survival among patients with lymph node metastases undergoing radical cystectomy.  Cancer 2008;112(11):2401-8. PMID:18383515
  
  
  
• Wright JL, Hotaling J, Porter MP.  Upper tract transitional cell carcinoma after primary bladder cancer:  a 15 year analysis.  J Urol 2009;181(3):1035-9.  PMID:19150569
  
  
  
• Wright JL, Morgan TM, Lin DW.  Primary scrotal cancer: survival patterns and increasing incidence.  Urology 2008;72(5);1139-43. PMID:18799208